PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $259,000 | -5.1% | 425,254 | +1.8% | 0.00% | 0.0% |
| Q1 2017 | $273,000 | +115.0% | 417,761 | +1.1% | 0.00% | +100.0% |
| Q4 2016 | $127,000 | -28.7% | 413,261 | +0.0% | 0.00% | 0.0% |
| Q3 2016 | $178,000 | +16.3% | 413,211 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $153,000 | -25.4% | 421,061 | -13.5% | 0.00% | -50.0% |
| Q1 2016 | $205,000 | -61.9% | 486,961 | +5.9% | 0.00% | -60.0% |
| Q4 2015 | $538,000 | -2.2% | 459,961 | -14.7% | 0.01% | -16.7% |
| Q3 2015 | $550,000 | -22.3% | 539,535 | -0.2% | 0.01% | -14.3% |
| Q2 2015 | $708,000 | +4.3% | 540,535 | +7.4% | 0.01% | 0.0% |
| Q1 2015 | $679,000 | -1.5% | 503,295 | +1.5% | 0.01% | -12.5% |
| Q4 2014 | $689,000 | +2.7% | 495,991 | +0.6% | 0.01% | 0.0% |
| Q3 2014 | $671,000 | -27.7% | 493,196 | -0.0% | 0.01% | -27.3% |
| Q2 2014 | $928,000 | -3.3% | 493,386 | -2.4% | 0.01% | -15.4% |
| Q1 2014 | $960,000 | +43.5% | 505,386 | +5.0% | 0.01% | +30.0% |
| Q4 2013 | $669,000 | +0.1% | 481,140 | +0.8% | 0.01% | -9.1% |
| Q3 2013 | $668,000 | +5.5% | 477,140 | -2.7% | 0.01% | 0.0% |
| Q2 2013 | $633,000 | – | 490,428 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|